Chidozie Ugwumba is a Managing Partner at SymBiosis Capital Management, where he invests in engineering biology and biotechnology across sectors including biotechnology, biotherapeutics, genetic medicines, cell therapies, biologics, precision small molecules, and computational techniques in biotech. He invests at Early Stage Venture through Series A–C, crossover, and public equity stages, and backs companies globally, including in the United States and Europe. He serves on the board of Paradox Immunotherapeutics and is a board observer at AdvanCell and Biosplice Therapeutics. He has invested in companies such as Carisma Therapeutics (NASDAQ: CARM), Micronoma, Clene Nanomedicine (NASDAQ: CLNN), MaaT Pharma, and Enterome. Chidozie is based in Bentonville, Arkansas, and studied at the Cornell Johnson Graduate School of Management, Amherst College, and Phillips Academy.
Chidozie Ugwumba, Managing Partner @ SymBiosis. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Chidozie Ugwumba from . Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Chidozie
Map your path to Chidozie instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Chidozie
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.